REG - Aptamer Group PLC - Block Listing Interim Review

AptamerAnnouncement

25/02/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250225:nRSY2691Ya&default-theme=true

RNS Number : 2691Y  Aptamer Group PLC  25 February 2025

 

25 February 2025

 

Aptamer Group plc

 

("Aptamer", the "Company" or the "Group")

 

Block Listing Interim Review

 

Aptamer Group plc (AIM: APTA), the developer of novel Optimer(®) binders to
enable innovation in the life sciences industry, makes the following
notification pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for
Companies regarding its existing block admission:

 

 Name of Company                                                                 Aptamer Group plc
 Name of Scheme                                                                  The Aptamer Group EMI Share Option Scheme
 Period of Return (from/to)                                                      25 August 2024 to 24 February 2025
 Number and class of securities not issued at the start of the period under the  1,666,477 Ordinary Shares
 scheme
 Number of securities issued under the scheme during the period                  0
 Number of securities lapsed/waived under the scheme during the period           1,090,424 Ordinary Shares
 Balance under the scheme of securities not yet issued at the end of the period  576,053 Ordinary Shares
 Number and class of securities originally admitted and the date of admission    2,063,200 Ordinary Shares on 25 February 2022
 Name of contact and telephone number                                            Andrew Rapson +44 (0) 1904 217 404

 

- Ends -

 

For further information, please contact:

 

 Aptamer Group plc                                               +44 (0) 1904 217 404 

 Arron Tolley, Chief Executive Officer
 SPARK Advisory Partners Limited - Nominated Adviser             +44 (0) 20 3368 3550 

 Andrew Emmott / Jade Bayat
 Turner Pope Investments (TPI) Limited - Broker                  +44 (0) 20 3657 0050 

 James Pope / Andrew Thacker 
 Northstar Communications Limited - Investor Relations           +44 (0) 113 730 3896

 Sarah Hollins

 

About Aptamer Group plc

 

Aptamer Group is a leading global developer of aptamer-based ligands that help
scientists remove the limits to discovery and innovation. Leveraging several
proprietary discovery and development platform, Aptamer delivers custom
affinity ligands, supported with a complete suite of characterisation and
validatory assays that enhance the translation of its binders and optimise
scientific outcomes for customers.

 

Aptamer's cutting-edge technology spans healthcare, research, personal care,
and industrial processes, delivering new affinity solutions for novel targets,
advanced diagnostics, and precision therapies. By working with industry
leaders in pharmaceutical, biotechnology, personal health, academic, and
clinical research sectors, Aptamer is accelerating science through the custom
development of tools and therapies.

 

To register for news alerts by email go to
https://aptamergroup.com/investors/investor-news-email-alerts/
(https://aptamergroup.com/investors/investor-news-email-alerts/)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRDZLFLELLLBBV